Embattled health care executive Martin Shkreli has been terminated as the CEO of KaloBios Pharmaceuticals, CNBC reports. He also resigned from the company's board of directors.
Shkreli, known for drastically hiking up drug prices, pleaded not guilty Thursday on charges of securities fraud and conspiracy. One day later, he resigned from his other CEO position, at Turing Pharmaceuticals.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"'Trying to find anything we could to stop him,' was the attitude of the government,” Shkreli said. "Beating the person up and then trying to find the merits to make up for it — I would have hoped the government wouldn't take that kind of approach."
-
Nvidia: unstoppable force, or powering down?Talking Point Sales of firm's AI-powering chips have surged above market expectations –but China is the elephant in the room
-
5 hard-working cartoons about Labor Day celebrationsCartoons Artists take on creation of AI, spelling mistakes, and more
-
Crossword: September 7, 2025The Week's daily crossword puzzle
-
New York court tosses Trump's $500M fraud fineSpeed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in IntelSpeed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to ChinaSpeed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with DisneySpeed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B dealSpeed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance mergerSpeed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profitsSpeed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new highSpeed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year
